Kontakt Hypoglykämie-Ambulanz/Insulinom-Sprechstunde

1.	Hirshberg B, Cochran C, Skarulis MC et al. Malignant insulinoma. Cancer 104, 264-272, 2005
2.	Starke AAR, Saddig C, Mansfeld L et al. Malignant metastatic insulinoma - postoperative treatment and follow-up. World J Surg 29, 789-793, 2005
3.	Warner RRP. Enteroendocrine tumors other than carcinoid: a review of clinically significant advances. Gastroenterology 128, 1668-1684, 2005
4.	Starke AAR, Saddig C. Hypoglykämien im Erwachsenenalter. In: Diabetes mellitus. Urban & Fischer, München Jena, 2.Aufl. 2000, S.775-782 ; Urban & Schwarzenberg, München Wien; 1. Aufl. 1995, S.643-650
5.	Marks V, Teale JD. Tumours producing hypoglycaemia. Endocrine-Related Cancer 5, 1998, 111-12
6.	Service FJ. Hypoglycemic disorders. N Engl J Med 332, 1995, 1144-1152
7.	Service FJ, McMahon M, O`Brien PC et al. Functioning insulinoma - incidence, recurrence, and longterm survival of patients: a 60 year study. Mayo Clin Proc 66, 1991, 711-719
8.	Rothmund M, Angelini L, Brunt LM et al. Surgery for benign insulinoma: an international review. World J Surg 14, 1990, 393-399
9.	Service FJ. Hypoglycemic disorders. Pathogenesis, diagnosis, and treatment, G.K.Hall Medical Publishers, Boston 1983, 187 S.
10.	Marks V, Rose FC. Hypoglycaemia. Blackwell Scientific Publ., Oxford London, 2. Aufl.1981, 522 S.
11.	Fajans SS, Floyd JC. Fasting hypoglycemia in adults. N Engl J Med 294, 1976, 766-772
12.	Creutzfeldt W, Arnold R, Creutzfeldt C et al. Biochemical and morphological investigations of 30 human insulinomas. Diabetologia 9, 1973, 217-231

Wissenschaftliche Originalarbeiten aus der Universitätsklinik Düsseldorf (Insulinom)

Original articles, Review articles, Letters - University of Duesseldorf (insulinoma)

1.	Saddig C, Goretzki PE, Starke AAR Differentiation of insulin secretion patterns in insulinoma. World J Surg 32, 918-929, 2008
2.	Letter : Pradeep PV, Mishra A, Mishra SK - Reply : Starke A Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome. World J Surg 31, 442-445, 2007
3.	Letter: Goretzki PE, Starke AAR. Coincidence of insulinoma with nesidioblastosis or false diagnosis in 2 of 15 patients ? Am J Surg Pathol 30, 919-920, 2006 Response: Anlauf M, Wieben D, Klöppel G, Raffel A, Knoefel W. Diffuse nesidioblastosis in adults and insulinoma: can they be associated ? Am J Surg Pathol 30, 920-921, 2006
4. OR	Starke AAR, Saddig C, Kirch B, Tschahargane C, Goretzki PE Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS) World J Surg 30, 670-679, 2006
5. OR	Starke AAR, Saddig C, Mansfeld L, Koester R, Tschahargane C, Czygan P, Goretzki PE Malignant metastatic insulinoma - postoperative treatment and follow-up World J Surg 29, 789-793, 2005
6. OR	Saddig C, Bender R, Starke AAR. A new classification plot for the C-peptide suppression test. JOP. J. Pancreas (Online) 2002; 3: 16-25
7. OR	Simon D, Starke A, Goretzki PE, Röher HD. Reoperative surgery for organic hyperinsulinism: indications and operative strategy. World J Surg 22, 666-672, 1998
8.	Röher HD, Simon D, Starke A, Goretzki PE. Special diagnostic and therapeutic aspects of insulinoma. Chirurg 68(2), 116-121, 1997
9. OR	Schumacher B, Lübke HJ, Frieling T, Strohmeyer G, Starke AAR. Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy 28, 273-276, 1996
10. OR	Starke AAR, Frilling A, Becker H, et al. Are CAT-scans necessary for preoperative localization of insulinomas ? Eur J Med 1: 411-413, 1992
11. OR	Sawicki PT, Heinemann L, Starke A, et al. Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma. Diabetologia 35: 649-652, 1992

Wissenschaftliche Originalarbeiten (Glucagon, KH-Stoffwechsel)
Original articles (Glucagon, carbohydrate metabolism)

1. OR	Starke AAR, Imamura T, Unger RH: Relationsship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration. J Clin Invest 79: 20-24,1987
2. OR	Starke AAR, Grundy S, McGarry JD, Unger RH: Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: Implications for human diabetes. Proc Natl Acad Sci USA 82, 1544-1546, 1985
3. OR	Starke AAR, Ehrhardt G, Berger M, Zimmermann H. Elevated glucagon in obesity. Diabetes 33: 277-280, 1984
4. OR	Starke AAR, Valverde I, Bottazzo GF, Tsotsalas M, Zimmermann H: Glucagon-deficiency associated with hypoglycemia and the absence of islet cell antibodies in the polyglandular failure syndrome before the onset of insulin-dependent diabetes mellitus. Diabetologia 25: 336-339, 1983
5. OR	Starke A, Keck E, Berger M, Zimmermann H. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus. Diabetologia 20: 547-552, 1981

Buchbeiträge, Übersichtsartikel (Endokrine Pankreastumoren), aktuelle abstracts

Review articles, book articles (endocrine tumors of the pancreas)

1.	Saddig C, Goretzki PE, Starke AAR. Differentiation of insulin secretion patterns in insulinoma. ISW 2007 Montreal
2a.	Starke AAR, Hilgers N, Meyer A, Saddig C, Goretzki PE. Diagnosis and therapy of non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS). Diabetes & Stoffwechsel 2007 (DDG - Jahrestagung, Hamburg 2007)
2b.	Starke AAR, Hilgers N, Meyer A, Pohl P, Lammers BJ, Saddig C, Goretzki PE. Therapy of non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS). Exp Clin Endocrinol Diabetes 115, Suppl. 1, S46, 2007 (51. DGE - Jahrestagung, Salzburg 2007)
3a.	Starke AAR, Knapp WH, Köster, Goretzki PE. [68Ga]-DOTATOC-PET-CT in non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS). Diabetes & Stoffwechsel 2007 (DDG-Hamburg 2007)
3b.	Starke AAR, Knapp WH, Köster R, Mansfeld L, Goretzki PE. [68Ga]-DOTATOC-PET and visualization of pancreatic islet cell hyperplasia / nesidioblastosis. Exp Clin Endocrinol Diabetes 115, Suppl. 1, S92, 2007 (DGE Salzburg 2007; 4th ENETS Conference Barcelona 2007; DDG Hamburg 2007)
4.	Starke AAR, Tschahargane C, Goretzki PE. Non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS): challenging differential diagnosis of classical insulinoma. Neuroendocrinology 88, p48 (C49), 2006 (3rd ENETS Conference Prague 2006)
5.	Starke AAR, Tschahargane C, Goretzki PE. Islet cell hyperplasia in adults - a not so rare cause of pancreatogenic non-insulinoma hypoglycemia. Exp Clin Endocrinol Diabetes 113, Suppl. 1, S13, 2005 (49. DGE - Jahrestagung, Münster 2005)
6.	Starke AAR, Saddig C, Goretzki PE, Mansfeld L, Koester R, Czygan P. Postoperative therapeutic strategies of malignant insulinoma with hepatic metastases. Exp Clin Endocrinol Diabetes 111, Suppl. 1, S64, 2003
7.	Saddig C, Starke AAR. Hypoglykämiediagnostik bei Patienten mit Verdacht auf Insulinom. internist. prax. 43, 43-57, 2003
8.	Starke AAR, Saddig C. Hypoglykämien im Erwachsenalter. In: Diabetes mellitus. Urban & Fischer, München Jena, 2.Aufl. 2000, S.775-782
9.	Starke AAR. Endokrines Pankreas: Glucagon. In: Kuemmerle, Hitzenberger, Spitzy (Hrsg.): Klinische Pharmakologie - Grundlagen und Methoden der Klinischen Pharmakologie und Pharmakotherapie. 4.Aufl. Ecomed-Verlag, Landsberg, 51. Erg-Lfg. 12/1996, 1-14
10.	Goretzki PE, Simon D, Starke A, Röher HD. Endokrine Pankreastumoren. Therapeutische Umschau 53, 408-412, 1996
11.	Starke AAR. Kommentar zu "Intraarterielle Calciumprovokation zur präoperativen Lokalisations--diagnostik des okkulten Insulinoms". Dtsch Med Wschr 118, 881-883, 1993
12.	Starke AAR. The determination of insulin sensitivity - methodological considerations. J Cardiovasc Pharmacol 20 (Suppl 11), 17-21, 1992
13.	Sawicki PT, Baba T, Berger M, Starke A. Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance. J Am Soc Nephrol 3 (Suppl 1), 64-S68, 1992
14.	Starke AAR, Röher HD. Der organische Hyperinsulinismus - Hungerversuch als Grundlage der Diagnose. Dt. Ärztebl. 88, C-1551, 1991
15.	Starke AAR. Das Glucagonom-Syndrom. Int Welt 9: 91-97, 1986